OtherSep 29, 2026, 10:46 AM
Genmab A/S Files September 2026 Form 6-K Report
AI Summary
Genmab A/S has filed a Form 6-K report with the SEC for the month of September 2026. This report is incorporated by reference into several of the company's registration statements on Form S-8. The filing includes the Articles of Association as an exhibit and was signed by Anthony Pagano, Executive Vice President & Chief Financial Officer.
Key Highlights
- Genmab A/S filed a Form 6-K report for the month of September 2026.
- The filing includes the company's Articles of Association as Exhibit 3.1.
- Anthony Pagano, Executive Vice President & Chief Financial Officer, signed the report.
Price Impact
More from GMAB